Search Results
IMW 2011: Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma
Maintenance Therapy In Multiple Myeloma: PHETEMA Study In High Risk Smoldering Multiple Myeloma
IMW 2011: Lenalidomide and continuous therapy for multiple myeloma
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma
The benefits of lenalidomide and dexamethasone for multiple myeloma
Dr. Landgren on the Treatment of High-Risk Smoldering Myeloma
IMW 2011: Tailoring therapy in elderly myeloma patients
Post-authorization safety of lenalidomide+dexamethasone in patients with multiple myeloma in Turkey
Smoldering myeloma: Who and when to treat?
Treatment strategies for smoldering myeloma
Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy for NDMM patients
Dr. San Miguel on Pembrolizumab With Lenalidomide/Dexamethasone in Multiple Myeloma
